3rd Quarter - Report

HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) for HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA)

Period 3rd Quarter 2011 Filed Oct 18, 2011 Signed by Patrick Kelly, Senior Vice President, Government Affairs

Official filing
Firm
HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA)
Client
HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA)
Income
—
Expenses
$264,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Joint Select Committee on Deficit Reduction; Full-year Continuing Appropriations Act, 2011 (H.R. 1); Final Fiscal Year 2011 Continuing Resolution (H.R. 1473); Budget Control Act of 2011 (H.R. 2693, S. 365, S. 627); Cut, Cap and Balance Act of 2011 (H.R. 2560); Continuing Appropriations Act of 2012 (H.R. 2608, H.R. 2017)

LobbyistCovered position, as disclosed
JEWELYN COSGROVE Intern, Senator Wayne Allard
KRISTEN FREITAS Director of Outreach, Congressman Dick Chrysler
ELIZABETH GALLENAGH Legislative Assistant, Representative Tom Manton
PATRICK MCANDREW KELLY —
THOMAS PHAN Professional Staff, Senate Aging Committee

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 627 (112th), H.R. 1 (112th), H.R. 2693 (112th), H.R. 2608 (112th), H.R. 1473 (112th), H.R. 2560 (112th), S. 365 (112th), H.R. 2017 (112th)

Pharmacy PHA

Importationof prescription drugs (S.319, H.R. 147), Rx Pedigree (H.R. 3026), Methamphetamine/Pseudoephedrine Regulation, NASPER Reauthorization (H.R. 866), Pill Mill Crackdown Act (H.R. 1065), Drug Abuse (S.507), Drug Shortages (S. 296/H.R. 2245), Cargo/Product Theft (S. 1002), Import Safety (S. 1584)

LobbyistCovered position, as disclosed
JEWELYN COSGROVE Intern, Senator Wayne Allard
KRISTEN FREITAS Director of Outreach,Congressman Dick Chrysler
ELIZABETH GALLENAGH Legislative Assistant, Representative Tom Manton
PATRICK MCANDREW KELLY —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 1584 (112th), S. 296 (112th), H.R. 1065 (112th), H.R. 3026 (112th), H.R. 866 (112th), S. 1002 (112th), S. 507 (112th), H.R. 147 (112th), H.R. 2245 (112th), S. 319 (112th)

Taxation/Internal Revenue Code TAX

LIFO Accounting Methodology

LobbyistCovered position, as disclosed
JEWELYN COSGROVE Intern, Senator Wayne Allard
KRISTEN FREITAS Director of Outreach, Congressman Dick Chrysler
ELIZABETH GALLENAGH Legislative Assistant, Representative Tom Manton
PATRICK MCANDREW KELLY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Average Sales Price (H.R. 905/S. 733), PPACA Implementation (PL 111-148)

LobbyistCovered position, as disclosed
JEWELYN COSGROVE Intern, Senator Wayne Allard
KRISTEN FREITAS Director of Outreach, Congressman Dick Chrysler
ELIZABETH GALLENAGH Legislative Assistant, Representative Tom Manton
PATRICK MCANDREW KELLY —
THOMAS PHAN Professional Staff, Senate Aging Committee

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: S. 733 (112th), H.R. 905 (112th)

Affiliated organisations

OrganisationLocation
AMERISOURCEBERGEN DRUG COMPANY Valley Forge, PA, US
CARDINAL HEALTH, INC. Dublin, OH, US
MCKESSON CORPORATION San Francisco, CA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.